staceywhite, Author at European Medical Journal - Page 143 of 195

Significant Improvement in Prostate Cancer Survival Rates Found

SIGNIFICANT improvements to survival rates in prostate cancer patients have been found to result from the addition of abiraterone to hormone therapy at…

New Technique for Assessing Psoriasis Severity

A HANDHELD tissue scanner has been developed for use in the management of patients with psoriasis, potentially enabling physicians to make a more…

New Test for the Detection of Latent HIV

A TEST for HIV has been created that the developers have stated will have greater efficacy, accuracy, and cost-effectiveness, possibly helping…

New Biomarker in Renal Replacement Therapy

SURVIVAL in patients undergoing renal replacement therapy could be improved by the utilisation of biomarker measurements, according to the results of a…

Stereotactic Ablative Radiation Therapy: A Better Alternative to Conventional Therapy?

TREATMENT of metastatic kidney cancer using a focussed therapy known as stereotactic ablative radiation has been shown to result in >90% control of…

The Importance of Civil Society Involvement in Eliminating Hepatitis C

This is an historic moment for hepatitis C treatment. With the advent of direct-acting antivirals (DAAs), we can now massively reduce the harm from an…

A Discussion on the Management of Wilson Disease

Prof Peter Ferenci opened the meeting by providing a background to Wilson disease (WD), an enigmatic condition where no two cases are the same. He explored…

Statins in Cirrhosis and Portal Hypertension

Statins have been used for almost three decades as cholesterol lowering drugs, yet additional effects…

Magnetic Resonance Imaging of Diffuse Liver Diseases

Virtual liver biopsy (VLB) can be considered a multicomponent imaging biomarker able to provide fundamental information on the presence, distribution…

Adenosine 2A Receptor Stimulation Prevents the Multiple Processes That Lead to Hepatic 'Immuno-Lipotoxicity' in Mice Fed a Methionine Choline-Deficient Diet and Blocks Non-Alcoholic Steatohepatitis Development

Non-alcoholic fatty liver disease (NAFLD) is a benign condition, but in ~20% of patients it can evolve into non-alcoholic steatohepatitis (NASH) with…